New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...

More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...

API scale-up success relies on choosing routes that balance efficiency, robustness, and manufacturability across development ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

TEMPE, Ariz.--(BUSINESS WIRE)--Addressing some of the most time-consuming challenges of biopharma companies in building clinical studies and rolling out drug trials, Anju Software has launched ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Outsourcing of non-core services and resources is common practice in today’s world as companies look to reduce overhead and costs and streamline their businesses. Pharmaceutical companies outsource ...

Gene and cell therapy have moved from the realm of science fiction to medical reality. These new therapies have the potential to permanently correct genetic disorders with a single administration. But ...

VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of pro ...